137 related articles for article (PubMed ID: 21508845)
1. Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension.
Meng L; Ye XJ; Ding WH; Yang Y; Di BB; Liu L; Huo Y
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):643-7. PubMed ID: 21508845
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels and potential roles of catestatin in patients with coronary heart disease.
Liu L; Ding W; Zhao F; Shi L; Pang Y; Tang C
Scand Cardiovasc J; 2013 Aug; 47(4):217-24. PubMed ID: 23688154
[TBL] [Abstract][Full Text] [Related]
3. Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling.
Meng L; Wang J; Ding WH; Han P; Yang Y; Qi LT; Zhang BW
Postgrad Med J; 2013 Apr; 89(1050):193-6. PubMed ID: 23223776
[TBL] [Abstract][Full Text] [Related]
4. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
[TBL] [Abstract][Full Text] [Related]
5. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
Demir M; Acartürk E; Inal T; Attila G; Dönmez Y; Avkaroğullari M; Cayli M
Cardiovasc Pathol; 2007; 16(2):69-74. PubMed ID: 17317538
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
Díez J; Laviades C
J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
Kartal O; Inal V; Baysan O; Sağlam K
Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
[TBL] [Abstract][Full Text] [Related]
8. Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction.
Wang X; Xu S; Liang Y; Zhu D; Mi L; Wang G; Gao W
Biomarkers; 2011 Jun; 16(4):372-7. PubMed ID: 21545240
[TBL] [Abstract][Full Text] [Related]
9. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
Rubattu S; Sciarretta S; Ciavarella GM; Venturelli V; De Paolis P; Tocci G; De Biase L; Ferrucci A; Volpe M
J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
[TBL] [Abstract][Full Text] [Related]
10. The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: Influence on high-density lipoprotein cholesterol.
Durakoğlugil ME; Ayaz T; Kocaman SA; Kırbaş A; Durakoğlugil T; Erdoğan T; Çetin M; Şahin OZ; Çiçek Y
Anatol J Cardiol; 2015 Jul; 15(7):577-85. PubMed ID: 25538000
[TBL] [Abstract][Full Text] [Related]
11. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
[TBL] [Abstract][Full Text] [Related]
13. [Association between blood pressure and circulating hormonal factors with left ventricular mass in patients with essential hypertension older than 55 years of age].
González Quijada S; Luque Otero M; Fernández-Cruz A; Almería C; Bagazgoitia Barrera J; Moya Marín FJ
Med Clin (Barc); 1997 Oct; 109(12):441-4. PubMed ID: 9441177
[TBL] [Abstract][Full Text] [Related]
14. Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years.
Strand AH; Gudmundsdottir H; Os I; Smith G; Westheim AS; Bjørnerheim R; Kjeldsen SE
J Hypertens; 2006 May; 24(5):905-13. PubMed ID: 16612253
[TBL] [Abstract][Full Text] [Related]
15. Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.
Rao F; Wen G; Gayen JR; Das M; Vaingankar SM; Rana BK; Mahata M; Kennedy BP; Salem RM; Stridsberg M; Abel K; Smith DW; Eskin E; Schork NJ; Hamilton BA; Ziegler MG; Mahata SK; O'Connor DT
Circulation; 2007 May; 115(17):2271-81. PubMed ID: 17438154
[TBL] [Abstract][Full Text] [Related]
16. [Left ventricular mass, diastolic function and collagen metabolism biomarkers in essential hypertension].
Macías Blanco C; Fatela-Cantillo D; Jiménez-Jiménez L; López Aguilar R; Moreno-Luna R; Doblas Delgado A; Stiefel P
Med Clin (Barc); 2012 Feb; 138(4):139-44. PubMed ID: 21939991
[TBL] [Abstract][Full Text] [Related]
17. An endogenous brake on the sympathetic nervous system: the emerging role of catestatin in hypertension.
Schillaci G; De Vuono S; Pucci G
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):609-12. PubMed ID: 21792021
[No Abstract] [Full Text] [Related]
18. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.
Sciarretta S; Ferrucci A; Ciavarella GM; De Paolis P; Venturelli V; Tocci G; De Biase L; Rubattu S; Volpe M
Am J Hypertens; 2007 Jul; 20(7):784-91. PubMed ID: 17586414
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study.
Morillas P; Castillo J; Quiles J; Nuñez D; Guillén S; Maceira A; Rivera M; Bertomeu V
Rev Esp Cardiol; 2008 Sep; 61(9):972-5. PubMed ID: 18775240
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between ambulatory blood pressure and left ventricular hypertrophy in essential hypertension].
Zhang WZ
Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun; 21(3):138-40, 185. PubMed ID: 8243224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
